Expression of Angiogenesis Regulatory Proteins and Epithelial-Mesenchymal Transition Factors in Platelets of the Breast Cancer PatientsReport as inadecuate




Expression of Angiogenesis Regulatory Proteins and Epithelial-Mesenchymal Transition Factors in Platelets of the Breast Cancer Patients - Download this document for free, or read online. Document in PDF available to download.

The Scientific World Journal - Volume 2014 2014, Article ID 878209, 7 pages -

Research Article

Department of Oncology, Qilu Hospital, School of Medicine, Shandong University, No. 107 Wenhua Xi Road, Jinan, Shandong 250012, China

Department of Oncology, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng 252000, China

Department of Oncology, Shandong Province-Owned Hospital, Shandong University, Jinan 250012, China

Department of Hematology, Liaocheng People’s Hospital, Medical School of Liaocheng, Taishan Medical University, 67 Dong Chang Xi Lu, Liaocheng, Shandong 252000, China

Received 21 February 2014; Accepted 14 August 2014; Published 14 October 2014

Academic Editor: Jahn M. Nesland

Copyright © 2014 Hui Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Platelets play a role in tumor angiogenesis and growth and are the main transporters of several angiogenesis regulators. Here, we aimed to determine the levels of angiogenesis regulators and epithelial-mesenchymal transition factors sequestered by circulating platelets in breast cancer patients and age-matched healthy controls. Platelet pellets PP and platelet-poor plasma PPP were collected by routine protocols. Vascular endothelial growth factor VEGF, platelet-derived growth factor BB PDGF-BB, thrombospondin-1 TSP-1, platelet factor 4 PF4, and transforming growth factor-β1 TGF-β1 were measured by enzyme-linked immunosorbent assay. Angiogenesis-associated expression of VEGF 2.1 pg-10

platelets versus 0.9 pg-10

platelets, , PF4 21.2 ng-10

platelets versus 10.2 ng-10

platelets, , PDGF-BB 42.9 pg-10

platelets versus 19.1 pg-10

platelets, , and TGF-β1 15.3 ng-10

platelets versus 4.3 ng-10

platelets, differed in the PP samples of cancer and control subjects. In addition, protein concentrations were associated with clinical characteristics . Circulating platelets in breast cancer sequester higher levels of PF4, VEGF, PDGF-BB, and TGF-β1, suggesting a possible target for early diagnosis. VEGF, PDGF, and TGF-β1 concentrations in platelets may be associated with prognosis.





Author: Hui Han, Fang-Li Cao, Bao-Zhong Wang, Xue-Ru Mu, Guang-Yao Li, and Xiu-Wen Wang

Source: https://www.hindawi.com/



DOWNLOAD PDF




Related documents